Literature DB >> 11289053

Familial aggregation of coronary artery calcium in families with type 2 diabetes.

L E Wagenknecht1, D W Bowden, J J Carr, C D Langefeld, B I Freedman, S S Rich.   

Abstract

Type 2 diabetes is widely recognized as a major risk factor for atherosclerotic cardiovascular disease, including subclinical atherosclerosis as measured by noninvasive procedures. However, the role of genetic factors that contribute to various measures of subclinical atherosclerosis is largely unknown. We hypothesize that subclinical atherosclerosis, measured as coronary artery calcification (CAC), will be extensive in individuals with type 2 diabetes and that its presence depends on both genetic and environmental factors. The genetic factors should result in the familial aggregation of CAC. To determine the extent of familial aggregation of CAC in the presence of type 2 diabetes, we studied 122 individuals with type 2 diabetes (mean age 60 years) and 13 individuals without diabetes in 56 families. CAC was measured by fast-gated helical computed tomography. Other measured factors included blood pressure, body size, lipids, HbA1c, and self-reported medical history. To test for an association between CAC and these factors while accounting for the potential familial correlation of CAC, generalized estimating equations were used. CAC was detectable in 80% of individuals with diabetes (median score 84, range 0-5,776). Extent of CAC, adjusted for age, was positively associated with male sex (P = 0.0003), reduced HDL (P = 0.02), albumin-to-creatinine ratio (P = 0.008), and cigarette pack-years (P = 0.03). CAC was also positively associated with a history of angina, myocardial infarction, stroke, and vascular procedures (all P < 0.01). HbA1c and fasting glucose were positively, but nonsignificantly, associated with the extent of CAC (P = 0.14 and 0.08, respectively). CAC, adjusted for age, sex, race, and diabetes status, was heritable (h2 = 0.50; P = 0.009). In multivariate analysis with additional adjustment for HDL, BMI, hypertension, and smoking, h2 = 0.40 (P = 0.038). These results suggest that strong (independent) genetic factors as well as environmental factors contribute to the variance of CAC in individuals with type 2 diabetes. In these data, CAC seems heritable and may serve as an important feature in designing studies to map genes contributing to both atherosclerosis and type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11289053     DOI: 10.2337/diabetes.50.4.861

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  57 in total

Review 1.  Searching for the mountains of the moon: genome scans for atherosclerosis.

Authors:  Michael A Province
Journal:  Curr Atheroscler Rep       Date:  2002-05       Impact factor: 5.113

Review 2.  Genetic determinants of diabetes and atherosclerosis.

Authors:  Braxton D Mitchell; Ikhide G Imumorin
Journal:  Curr Atheroscler Rep       Date:  2002-05       Impact factor: 5.113

3.  Genetic epidemiology of subclinical cardiovascular disease in the diabetes heart study.

Authors:  D W Bowden; A B Lehtinen; J T Ziegler; M E Rudock; J Xu; L E Wagenknecht; D M Herrington; S S Rich; B I Freedman; J J Carr; C D Langefeld
Journal:  Ann Hum Genet       Date:  2008-04-29       Impact factor: 1.670

4.  The influence of subclinical cardiovascular disease and related risk factors on cognition in type 2 diabetes mellitus: The DHS-Mind study.

Authors:  Christina E Hugenschmidt; Fang-Chi Hsu; Satoru Hayasaka; J Jeffrey Carr; Barry I Freedman; David L Nyenhuis; Jeff D Williamson; Donald W Bowden
Journal:  J Diabetes Complications       Date:  2013-05-07       Impact factor: 2.852

5.  The association of coronary artery calcification and carotid artery intima-media thickness with distinct, traditional coronary artery disease risk factors in asymptomatic adults.

Authors:  Evadnie Rampersaud; Lawrence F Bielak; Afshin Parsa; Haiqing Shen; Wendy Post; Kathleen A Ryan; Patrick Donnelly; John A Rumberger; Patrick F Sheedy; Patricia A Peyser; Alan R Shuldiner; Braxton D Mitchell
Journal:  Am J Epidemiol       Date:  2008-09-19       Impact factor: 4.897

6.  Cross-sectional analysis of calcium intake for associations with vascular calcification and mortality in individuals with type 2 diabetes from the Diabetes Heart Study.

Authors:  Laura M Raffield; Subhashish Agarwal; Amanda J Cox; Fang-Chi Hsu; J Jeffrey Carr; Barry I Freedman; Jianzhao Xu; Donald W Bowden; Mara Z Vitolins
Journal:  Am J Clin Nutr       Date:  2014-08-06       Impact factor: 7.045

Review 7.  Genetics of diabetes complications.

Authors:  Donald W Bowden
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

8.  Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study.

Authors:  Ryan L McKimmie; Kurt R Daniel; J Jeffrey Carr; Donald W Bowden; Barry I Freedman; Thomas C Register; Fang-Chi Hsu; Kurt K Lohman; Richard B Weinberg; Lynne E Wagenknecht
Journal:  Am J Gastroenterol       Date:  2008-10-03       Impact factor: 10.864

Review 9.  Vascular health in children and adolescents: effects of obesity and diabetes.

Authors:  Kevin R Short; Piers R Blackett; Andrew W Gardner; Kenneth C Copeland
Journal:  Vasc Health Risk Manag       Date:  2009-11-16

10.  Human lipoxygenase pathway gene variation and association with markers of subclinical atherosclerosis in the diabetes heart study.

Authors:  Kathryn P Burdon; Megan E Rudock; Allison B Lehtinen; Carl D Langefeld; Donald W Bowden; Thomas C Register; Yongmei Liu; Barry I Freedman; J Jeffrey Carr; Catherine C Hedrick; Stephen S Rich
Journal:  Mediators Inflamm       Date:  2010-05-31       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.